News Angle produces new data backing liquid biopsy in cancer Angle hopes Parsortix will be first approved cell-based liquid biopsy.
News Major trial for potential 'game changer' cancer diagnostic b... Breath Biopsy will be tested in its ability to detect several cancers earlier than traditional methods.
News Angle poised to take on US cancer diagnostics market Circulating tumour cell test could help select drug therapy.
News Theranos settles with investor on claims it lied about busin... Partner Fund Management agrees to drop lawsuits.
News Health insurer spots potential of Owlstone's lung cancer bre... The venture capital arm of the UK’s biggest insurance firm Aviva is to invest $5 million (£4m) in Owlstone Medical, one of the country’s most promising and potentially groundbreaking diagno
News 'Repeated violations' behind Theranos lab closure CMS report describes failures meeting its own quality control procedures.
News OpenBind unveils its first AI model for drug discovery A research consortium that aims to make the UK a leader in AI-driven drug discovery, OpenBind, has hit its first major milestone.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
